Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Effectiveness of Mass Drug Administration (MDA) With Dihydroartemisinin + Piperaquine for Reducing Malaria Parasite Infection Prevalence and Incidence in Southern Province Zambia

NCT02329301 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT02329301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02329301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Effectiveness of Mass Drug Administration (MDA) With Dihydroartemisinin + Piperaquine for Reducing Malaria Parasite Infection Prevalence and Incidence in Southern Province Zambia
Lead sponsor
PATH
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
August 31, 2020
Enrollment
2,430 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, malaria, falciparum